Artificial Intelligence-Assisted Expressive Writing Intervention to Improve Adolescent Emotional Distress: A Cluster Randomized Controlled Trial
Sponsor: Peking University
Trial Details
| Condition | Emotional Disturbance, Emotional Regulation, Insomnia |
| Intervention | AI-GNW; NF-GNW; NWG |
| Phase | NA |
| Status | Completed |
| Participants | 486 |
| Est. Completion | 25 Oct 2025 |
| Last Updated | 10 June 2026 |
Primary Outcome
Revised Child Anxiety and Depression Scale (RCADS)
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Native speakers of Chinese who are proficient in reading and writing Chinese. * Signed a informed consent form and voluntarily agreed to participate. * Owns a smartphone, tablet, or similar electronic device and is able to complete the required questionnaires and writing tasks. Exclusion Criteria: * Prior clinical diagnosis of schizophrenia or any other major psychiatric disorder. * Presence of severe cognitive impairment, language-expression difficulties, or any other condition that would impede writing ability. * Participation in another similar psychological intervention or psychotherapy within the past three months. * Inability to tolerate a group-based intervention setting due to personal health conditions (e.g., serious illness). * Unwillingness or inability to provide necessary cooperation or to sign the informed consent form.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service